This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Gilead Sciences, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: David L Kukla: Innovator in Cancer Treatment
Introduction
David L Kukla is a notable inventor based in Newcastle, WA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of cancer treatments. His innovative work has led to the creation of a patent that addresses critical medical needs.
Latest Patents
David L Kukla holds a patent for PARP7 inhibitors. This patent includes a compound of Formula I or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers, or deuterated analog thereof. The patent also describes a pharmaceutical composition comprising this compound, along with a pharmaceutically acceptable excipient. Furthermore, it outlines a method of treating cancer using the same.
Career Highlights
David is currently employed at Gilead Sciences, Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise and dedication have positioned him as a valuable asset in the fight against cancer.
Collaborations
Throughout his career, David has collaborated with esteemed colleagues such as Seung H Lee and Leena Patel. These partnerships have fostered an environment of innovation and progress in their shared field.
Conclusion
David L Kukla's contributions to cancer treatment through his patent on PARP7 inhibitors exemplify his commitment to advancing medical science. His work at Gilead Sciences, Inc. and collaborations with other professionals highlight the importance of teamwork in achieving groundbreaking innovations.